Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts $106.54 +2.33 (+2.24%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Gilead Sciences Earnings Summary Latest Q1 Earnings DateApr. 24EstimatedConsensus EPS (Apr. 24) $1.77 Actual EPS (Apr. 24) $1.81 Beat By $0.04 Actual Revenue (Apr. 24) $6.67BGilead Sciences announced Q1 2025 earnings on April 24, 2025, reporting an EPS of $1.81, which beat the consensus estimate of $1.77 by $0.04. Quarterly revenue fell .3% year-over-year to $6.67 billion, below analysts' expectations of $6.77 billion. With a trailing EPS of $4.75 and a P/E Ratio of 287.95, Gilead Sciences' earnings are expected to grow 2.01% next year, from $7.95 to $8.11 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Gilead Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gilead Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Gilead Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252$1.72$1.98$1.85 Q2 20252$1.92$2.02$1.97 Q3 20252$2.03$2.06$2.05 Q4 20252$1.72$2.03$1.88 FY 20258$7.39$8.09$7.74 Q1 20261$1.69$1.69$1.69 Q2 20261$1.84$1.84$1.84 Q3 20261$2.20$2.20$2.20 Q4 20261$2.29$2.29$2.29 FY 20264$8.02$8.02$8.02 Q1 20271$1.88$1.88$1.88 Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/24/2025Q1 2025$1.77$1.81+$0.04$1.04$6.77B$6.67B2/11/2025Q4 2024$1.67$1.90+$0.23$1.42$7.15B-11/6/2024Q3 2024$1.58$2.02+$0.44$3.04$7.01B$7.55B8/8/2024Q2 2024$1.61$2.01+$0.40$2.73$6.64B$6.95B4/25/2024Q1 2024-$1.49-$1.32+$0.17$0.70$6.36B$6.69B2/6/2024Q4 2023$1.76$1.72 -$0.04$2.30$7.10B$7.12B11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81B$7.05B8/3/2023Q2 2023$1.64$1.34 -$0.30$1.85$6.45B$6.60B Gilead Sciences Earnings - Frequently Asked Questions When did Gilead Sciences announce their last quarterly earnings? Gilead Sciences (NASDAQ:GILD) last announced its quarterly earning data on Thursday, April 24, 2025. Learn more on GILD's earnings history. What guidance has Gilead Sciences issued on next quarter's earnings? Gilead Sciences issued an update on its FY 2025 earnings guidance on Thursday, April, 24th. The company provided EPS guidance of 7.700-8.100 for the period, compared to the consensus EPS estimate of 7.950. The company issued revenue guidance of $28.2 billion-$28.6 billion, compared to the consensus revenue estimate of $28.7 billion. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported $1.81 earnings per share (EPS) to beat the analysts' consensus estimate of $1.77 by $0.04. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $28.74 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $480 million. GILD has generated $4.75 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 287.95 and a forward price-to-earnings ratio of 13.40. The price/earnings-to-growth ratio is 0.71. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $7.95 per share to $8.11 per share in the next year, which is a 2.01% increase. More Earnings Resources from MarketBeat Related Companies AMGN Earnings Date VRTX Earnings Date REGN Earnings Date ALNY Earnings Date BIIB Earnings Date UTHR Earnings Date BMRN Earnings Date INCY Earnings Date EXEL Earnings Date NBIX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:GILD) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GILD Stock Free GILD Stock Alerts